Psilocybin-Assisted Therapy for Physician Well-Being and Burnout
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age21-70
SponsorUniversity of California, San Diego
About this trial
Through an open-label study involving a small group of UCSD physicians experiencing burnout, the investigators will evaluate the feasibility, safety, and preliminary effectiveness of PAT to reduce burnout symptoms.
Eligibility criteria
Qualifiers
UCSD faculty physician, aged 21-70. Volunteer faculty are not included
Meets criteria for physician burnout
Experiencing symptoms of burnout for >6 months
Able to complete all required study visits
Disqualifiers
Previous inpatient psychiatric hospitalization(s)
Previously diagnosed with a psychotic disorder (schizophrenia, schizoaffective disorder, or other psychotic spectrum disorder), bipolar spectrum disorder, personality disorder (borderline personality disorder, antisocial personality disorder, or other severe personality disorders), any severe psychiatric disorder.
Exhibiting elevated suicide risk
First degree family history of psychosis or bipolar disorder
Trial design
Treatments tested in this trial
- Psilocybin, [3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov